Atlas Trials

Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer

Clinical trial NCT01207895 · COMPLETED

Trial details

NCT number
NCT01207895
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2010-03-01
Primary completion
2012-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.